(Press-News.org) Copenhagen, Denmark: More than three months after suffering from mild COVID infection, men have lower sperm concentrations and fewer sperm that are able to swim, according to new findings presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1].
Professor Rocio Núñez-Calonge, scientific advisor at UR International Group at the Scientific Reproduction Unit, Madrid (Spain), said that after an average of 100 days following SARS-CoV-2 infection there appeared to be no improvement in sperm quality and concentration, even though new sperm would have been produced in that time.
“There have been previous studies that show semen quality is affected in the short term following a COVID infection but, as far as we are aware, none that have followed men for a longer period of time,” she said. “We assumed that semen quality would improve once new sperm were being generated, but this was not the case. We do not know how long it might take for semen quality to be restored and it may be the case that COVID has caused permanent damage, even in men who suffered only a mild infection.”
Prof. Núñez-Calonge and colleagues had observed that, in some men attending clinics in Spain for assisted reproduction treatment, semen quality was worse after COVID infection than before the infection even though they had recovered and the infection was mild. So they decided to investigate if COVID had influenced the decline in quality.
“Since it takes approximately 78 days to create new sperm, it seemed appropriate to evaluate semen quality at least three months after recovery from COVID,” said Prof. Núñez-Calonge.
Between February 2020 and October 2022, the researchers recruited 45 men attending six reproductive clinics in Spain to the study. All had a confirmed diagnosis of mild COVID, and the clinics had data from analysis of semen samples taken before the men were infected. Another semen sample was taken between 17 and 516 days after infection. The median (average) age of the men was 31, and the amount of time that elapsed between the pre- and post-COVID samples was a median of 238 days. The researchers analysed all the samples taken up to 100 days after infection, and then analysed a subset of samples taken more than 100 days later.
They found a statistically significant difference in semen volume (down 20% from 2.5 to 2 millilitres), sperm concentration (down 26.5% from 68 to 50 million per ml of ejaculate), sperm count (down 37.5% from 160 to 100 million per millilitre of semen), total motility i.e. being able to move and swim forwards (down 9.1% from 49% to 45%) and numbers of live sperm (down 5% from 80% to 76%).
Prof. Núñez-Calonge said motility and the total sperm count were the most severely affected. Half of the men had total sperm counts that were 57% lower after COVID compared to their pre-COVID samples. The shape of the sperm was not significantly affected.
When the researchers looked at the group of men who provided a sample later than 100 days after COVID, they found that sperm concentration and motility had still not improved over time.
“The continuing effect of COVID infection on semen quality in this later period may be caused by permanent damage due to the virus, even in mild infection. We believe clinicians should be aware of the damaging effects of SARS-CoV-2 virus on male fertility. It is particularly interesting that this decrease in semen quality occurs in patients with mild COVID infection, which means that the virus can affect male fertility without the men showing any clinical symptoms of the disease,” said Prof. Núñez-Calonge.
It is known that the SARS-CoV-2 virus can affect the testicles and sperm, but the mechanism is still unknown. Prof. Núñez-Colange says that inflammation and damage to the immune system that is seen in patients with long COVID might be involved.
“The inflammatory process can destroy germ cells by infiltrating the white blood cells involved in the immune system, and reduce testosterone levels by affecting the interstitial cells that produce the male hormone,” she said.
“It should be mentioned that impairment of semen parameters may not be due to a direct effect of the SARS-CoV-2 virus. There are likely to be additional factors that contribute to long-term sperm parameters decrease, but whose identity is currently unknown. Furthermore, we did not measure hormonal levels in this study: intense changes in testosterone, a key player involved in male reproductive health, has previously been reported in COVID-infected male patients.”
The researchers plan to continue to study the men to measure both semen quality and hormonal status over time. They believe there should be more research into the reproductive functions of men after COVID infection to see if their fertility is affected temporarily or permanently.
The chair of ESHRE, Professor Carlos Calhaz-Jorge from the Northern Lisbon Hospital Centre and the Hospital de Santa Maria in Lisbon (Portugal), was not involved in this research. He commented: “This is interesting research by Prof. Núñez-Calonge and her colleagues and shows the importance of long-term follow-up of fertility patients after a COVID infection, even if it’s a mild infection. However, it’s important to note that the semen quality in these patients after a COVID infection is still within the World Health Organization’s criteria for ‘normal’ semen and sperm. So, it is unclear whether these reductions in semen quality after a COVID infection translate into impaired fertility and this should be the subject of further research.”
(ends)
[1] Presentation no: O-020, “What is the recovery time for sperm parameters in men who have suffered a mild Covid-19 infection?” presented by Professor Rocio Núñez-Calonge, Session 04: Factors influencing sperm (dys)function, Hall D1, 11.15 hrs CEST, Monday 26 June 2023.
Notes for editors
According to the UK Academy of Medical Science’s press release labelling system, this is a non-peer reviewed, observational study in people.
Funding: The study received no financial support.
When obtaining outside comment, journalists are requested to ensure that their contacts are aware of the embargo on this release.
For further information, contact:
Emma Mason
Email: wordmason@mac.com
Mobile: +44 (0)7711 296986
Kerry Noble
Email: kerry_noble@hotmail.com
Mobile: +44 (0)7446 869 433
Sophie Goodchild
Email: goodchildsophie@hotmail.com
Mobile: +44 (0)7767 325595
Laura Rossignoli at ESHRE
Email: Laura@eshre.eu
Mobile: +32 (0)499 92 32 49
The European Society of Human Reproduction and Embryology (ESHRE) is a European non-profit organisation with international membership, whose main mission is to promote the study and research of reproductive science and medicine as well as the treatment of infertility. Established in 1984, the Society now comprises more than 9.000 members and has become the leading Society in reproductive science and medicine worldwide. Our members are medical professionals, scientists and researchers working in reproductive science, reproductive medicine and embryology. We work in close partnership with the patient organisation Fertility Europe. The ESHRE annual meeting attracts over 11,000 clinicians, researchers, scientists, exhibitors. In 2022, participants from 130 countries attended. Seven of the top ten countries represented were European.
END
Men experience a long-term drop in semen quality after COVID infection – even if the infection was mild
2023-06-26
ELSE PRESS RELEASES FROM THIS DATE:
Cheap and safe hormone treatment shows promise for couples with unexplained infertility
2023-06-26
Copenhagen, Denmark: A small study with couples experiencing unexplained infertility suggests that a hormone treatment could increase the chances of having a baby.
The trial, presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1], compared couples trying to conceive naturally with couples where the woman used a vaginal progesterone treatment during the second half of her menstrual cycle.
The researchers say a larger trial is now warranted but, given the treatment is safe and low-cost, it could ultimately benefit many people living with infertility around the world.
The study ...
50-million-year-old katydid fossil reveals muscles, digestive tract, glands and a testicle
2023-06-26
CHAMPAIGN, Ill. — 50 million years ago in what is now northwestern Colorado, a katydid died, sank to the bottom of a lake and was quickly buried in fine sediments, where it remained until its compressed fossil was recovered in recent years. When researchers examined the fossil under a microscope, they saw that not only had many of the insect’s hard structures been preserved in the compressed shale, so had several internal organs and tissues, which are not normally fossilized.
They describe their findings in the journal Palaeoentomology.
“Katydids ...
Are more babies born if embryos are cultured for three or five days in the lab? Largest randomised clinical trial to date suggests that age matters
2023-06-26
Copenhagen, Denmark: Women are just as likely to give birth to live babies after fertility treatment if embryos are transferred to their wombs three days after fertilisation in the laboratory rather than five. However, the women’s age can affect the outcomes, according to new research presented to the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1].
Dr Simone Cornelisse, a researcher and resident in obstetrics and gynaecology at Radboud University Medical Center, Nijmegen (The Netherlands), told the conference that among 1202 women from 21 Dutch fertility centres who were randomly assigned to have embryos transferred to their wombs ...
Cancer risk among women with polycystic ovary syndrome doubles after menopause
2023-06-26
Copenhagen, Denmark: Women with polycystic ovary syndrome (PCOS) are not at any greater risk of ovarian cancer than those without the common hormone condition, say researchers. However, those with PCOS who have been through the menopause are more than twice as likely to be diagnosed with ovarian cancer.
The data based on nearly two million women is presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1]. The research is also published simultaneously in the International Journal of Cancer [2].
This ...
Humans’ evolutionary relatives butchered one another 1.45 million years ago
2023-06-26
Researchers from the Smithsonian’s National Museum of Natural History have identified the oldest decisive evidence of humans’ close evolutionary relatives butchering and likely eating one another.
In a new study published today, June 26, in Scientific Reports, National Museum of Natural History paleoanthropologist Briana Pobiner and her co-authors describe nine cut marks on a 1.45 million-year-old left shin bone from a relative of Homo sapiens found in northern Kenya. Analysis of 3D models of the fossil’s surface revealed ...
Childhood cancer: Vulnerability in the immune response against metastases discovered
2023-06-26
Scientists led by Sabine Taschner-Mandl, PhD, St. Anna Children's Cancer Research Institute, and Nikolaus Fortelny, PhD, Paris Lodron University of Salzburg, are the first to analyze bone marrow metastases from childhood tumors of the nervous system using modern single-cell sequencing analysis. It turns out that cancer cells prevent cells in their environment from fighting the tumor – a process that could be reversed with medication. The findings were published in the renowned journal Nature Communications.
Neuroblastoma is the most ...
Novel study deepens knowledge of treatment-resistant hypertension
2023-06-26
For many patients with hypertension—an elevated blood pressure that can lead to stroke or heart attack—medication keeps the condition at bay. But what happens when medication that physicians usually prescribe doesn’t work? Known as apparent resistant hypertension (aRH), this form of high blood pressure requires more medication and medical management.
Novel research from investigators in the Smidt Heart Institute at Cedars-Sinai, published today in the peer-reviewed journal Hypertension, found that aRH prevalence was lower in ...
Progesterone decreases night sweats & improves sleep in perimenopausal women
2023-06-26
New controlled trial research documents that Progesterone (micronized, oral) is effective at decreasing night sweats and improving sleep in perimenopausal women who have menstruated in the last 1-year. Perimenopausal women most want treatment for these two symptoms.
Current guidelines prescribe Menopausal Hormone Therapy (MHT) for disturbing hot flushes/flashes or night sweats (vasomotor symptoms, VMS) in all women younger than 60 years.
“This guideline assumes that hormone levels and symptoms are the same in the early years of ...
What are the endometrial cancer risks and trends among different African descent populations?
2023-06-26
Study reveals some distinctions between Black women in the US and the French Caribbean but increasing trends for aggressive forms in both regions.
Compared with white women, Black women have elevated risks of being diagnosed with advanced uterine cancer—also known as endometrial cancer—and of developing aggressive tumors. Researchers recently compared the incidence and trends for endometrial cancer, both overall and by subtype, between African descent women in Florida and women in the French Caribbean—specifically, the islands of Martinique and Guadeloupe. The findings are published by Wiley online ...
Endometrial cancer risk and trends among distinct African-descent populations
2023-06-26
MIAMI, FLORIDA (EMBARGOED UNTIL 3:01 AM ET Monday, June 26, 2023) – Current evidence indicates Black women in the U.S. are at greater risk of developing advanced uterine cancer, also known as endometrial cancer, and of developing its more aggressive form – non-endometroid cancer – than white women.
But research to date has mostly studied Black women as a homogenous group, and there is limited data about specific African-descent subpopulations worldwide. That is until now.
A new study by researchers with Sylvester Comprehensive Cancer Center and the University of Miami Miller School of Medicine compared both the overall incidence and trends for endometrial ...